We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$63.1B
AUM Growth
+$3.79B
Cap. Flow
-$1.12B
Cap. Flow %
-1.77%
Top 10 Hldgs %
32.11%
Holding
999
New
156
Increased
303
Reduced
370
Closed
127

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$509M
2
RPRX icon
Royalty Pharma
RPRX
+$216M
3
JNJ icon
Johnson & Johnson
JNJ
+$159M
4
PG icon
Procter & Gamble
PG
+$134M
5
LBRDK icon
Liberty Broadband Class C
LBRDK
+$133M

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$1.35B
2
INSM icon
Insmed
INSM
+$197M
3
HUBB icon
Hubbell
HUBB
+$191M
4
ARGX icon
argenx
ARGX
+$164M
5
SLNO
Soleno Therapeutics
SLNO
+$161M

Sector Composition

Rank Sector Weight
1 Technology 30.31%
2 Healthcare 13.97%
3 Financials 11.89%
4 Consumer Discretionary 9.55%
5 Communication Services 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBRA icon
601
Sabra Healthcare REIT
SBRA
$5.34B
$11.8M 0.02%
+635,000
New +$11.9M
ESS icon
602
Essex Property Trust
ESS
$18.3B
$11.7M 0.02%
43,600
-28,032
-39% -$7.58M
MCHP icon
603
Microchip Technology
MCHP
$40.4B
$11.6M 0.02%
181,300
+53,700
+42% +$3.64M
RMD icon
604
ResMed
RMD
$32.4B
$11.6M 0.02%
42,531
+40,432
+1,926% +$11M
TPR icon
605
Tapestry
TPR
$32.7B
$11.6M 0.02%
102,323
-172,877
-63% -$18.1M
AXS icon
606
AXIS Capital
AXS
$7.62B
$11.5M 0.02%
120,000
+90,000
+300% +$8.72M
PRVA icon
607
Privia Health
PRVA
$2.77B
$11.3M 0.02%
+453,275
New +$9.75M
ROL icon
608
Rollins
ROL
$17.7B
$11.1M 0.02%
189,342
+156,892
+483% +$8.92M
NDSN icon
609
Nordson
NDSN
$17.2B
$11.1M 0.02%
48,900
+19,400
+66% +$4.28M
TSHA icon
610
Taysha Gene Therapies
TSHA
$1.82B
$10.9M 0.02%
3,328,000
-1,511,000
-31% -$4.28M
REG icon
611
Regency Centers
REG
$14.1B
$10.8M 0.02%
148,800
-800
-0.5% -$57.1K
HLX icon
612
Helix Energy Solutions
HLX
$1.45B
$10.8M 0.02%
1,650,000
– –
MLTX icon
613
MoonLake Immunotherapeutics
MLTX
$1.53B
$10.8M 0.02%
+1,500,000
New +$78.2M
KLAR
614
Klarna Group
KLAR
$7.66B
$10.7M 0.02%
+292,713
New +$12.5M
PCRX icon
615
Pacira BioSciences
PCRX
$1.02B
$10.6M 0.02%
+409,997
New +$10.1M
SJM icon
616
J.M. Smucker
SJM
$12.7B
$10.5M 0.02%
97,127
-300
-0.3% -$32.6K
TUSK icon
617
Mammoth Energy Services
TUSK
$142M
$10.5M 0.02%
4,575,000
– –
FSBC icon
618
Five Star Bancorp
FSBC
$1.12B
$10.4M 0.02%
324,077
+30,828
+11% +$968K
SWKS icon
619
Skyworks Solutions
SWKS
$10.1B
$10.4M 0.02%
135,150
-2,400
-2% -$179K
MOD icon
620
Modine Manufacturing
MOD
$10.2B
$10.4M 0.02%
73,000
-214,531
-75% -$27.3M
BG icon
621
Bunge Global
BG
$20.9B
$10.4M 0.02%
127,500
+4,400
+4% +$353K
EGP icon
622
EastGroup Properties
EGP
$10.8B
$10.3M 0.02%
60,646
-21,874
-27% -$3.63M
ZS icon
623
Zscaler
ZS
$26.3B
$10.2M 0.02%
+34,000
New +$9.69M
WSM icon
624
Williams-Sonoma
WSM
$29.1B
$10.2M 0.02%
52,000
-208,600
-80% -$39.9M
NCLH icon
625
Norwegian Cruise Line
NCLH
$8.89B
$10.1M 0.02%
411,400
+2,200
+0.5% +$53.4K
23 24
25
26 27

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Adage Capital Partners held 999 positions worth $63.1B, up 6.4% from $59.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Adage Capital Partners's Q3 2025 filing shows 156 new, 303 increased, 370 reduced and 127 closed positions. Its largest new stake was Chevron: 3,284,841 shares worth $510M. The largest sale was Hess, an estimated $1.35B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2025 buy was Chevron: 3,284,841 shares worth $510M.
  • Adage Capital Partners added most to Royalty Pharma in Q3 2025, an estimated $216M increase.
  • Adage Capital Partners's biggest Q3 2025 reduction was Insmed, cutting an estimated $197M.
  • Adage Capital Partners fully exited Hess in Q3 2025, selling an estimated $1.35B.
  • Adage Capital Partners's ten largest holdings make up 32% of its $63.1B portfolio in Q3 2025.
  • Adage Capital Partners opened 156 new positions and closed 127 in Q3 2025.
  • Adage Capital Partners's portfolio value rose 6.4% quarter-over-quarter to $63.1B.

Based on Adage Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.